Pharmacokinetics of methylprednisolene acetate after intra-articular administration and its effect on endogenous hydrocortisone and cortisone secretion in horses

American Journal of Veterinary Research

Volumn 67, Issue 4, 2006, Pages 654-662

  Soma, Lawrence R ^a   Uboh, Cornelius E ^b   Luo, Yi ^a   Guan, Fuyu ^a   Moate, Peter J ^a   Boston, Ray C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WEST CHESTER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTISONE; HYDROCORTISONE; METHYLPREDNISOLONE ACETATE; ANTIINFLAMMATORY AGENT; DRUG DERIVATIVE; METHYLPREDNISOLONE;

ANALYTIC METHOD; ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE RELEASE; HORMONE SYNTHESIS; HORSE; HYDROCORTISONE RELEASE; MALE; MASS SPECTROMETRY; NONHUMAN; SENSITIVITY ANALYSIS; ANIMAL; BLOOD; INTRAARTICULAR DRUG ADMINISTRATION; KINETICS; SECRETION;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CORTISONE; HORSES; HYDROCORTISONE; INJECTIONS, INTRA-ARTICULAR; KINETICS; METHYLPREDNISOLONE;

EID: 33646826693     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.67.4.654     Document Type: Article

References (50)

1. Toutain PL, Koritz GD, Fayolle PM, et al. Pharmacokinetics of methylprednisolone, methylprednisolone sodium succinate, and methylprednisolone acetate in dogs. J Pharm Sci 1986;75:251-255.
2. Ferguson DC, Hoenig M. Corticosteroids, mineral corticoids, and steroid synthesis inhibitors. In: Adams HR, ed. Veterinary pharmacology therapeutics. 8th ed. Ames, Iowa: Iowa State University Press, 2001;658.
3. Centeno LM, Moore ME. Preferred intraarticular corticosteroids and associated practice: a survey of members of the American College of Rheumatology. Arthritis Care Res 1994;7:151-155.
4. Autefage A, Alvinerie M, Toutain PL. Synovial fluid and plasma kinetics of methylprednisolone and methylprednisolone acetate in horses following intra-articular administration of methyl-prednisolone acetate. Equine Vet J 1986;18:193-198.
5. Lillich JD, Bertone AL, Schmall LM, et al. Plasma, urine, and synovial fluid disposition of methylprednisolone acetate and isoflupredone acetate after intra-articular administration in horses. Am J Vet Res 1996;57:187-192.
6. Toutain PL, Alvinerie M, Fayolle P, et al. Bovine plasma and synovial fluid kinetics of methylprednisolone and methylprednisolone acetate after intra-articular administration of methylprednisolone acetate. J Pharmacol Exp Ther 1986;236:3.
7. McKay AG, Milne FJ. Observations on the intraarticular use of corticosteroids in the racing thoroughbred. J Am Vet Med Assoc 1976;168:1039-1041.
8. Owen RA, Marsh JA, Hallett FR, et al. In tra-articular corticosteroid- and exercise-induced arthropathy in a horse. J Am Vet Med Assoc 1984;184:302-308.
9. Trotter GW. Intra-articular corticosteroids. In: McIlwraith CW, Trotter GW, eds. Joint disease in the horse. Philadelphia: WB Saunders Co, 1996;237-256.
10. Trotter GW, McIlwraith CW, Yovich JV, et al. Effects of intra-articular administration of methylprednisolone acetate on normal equine articular cartilage. Am J Vet Res 1991;52:83-87.
11. Armstrong RD, English J, Gibson T, et al. Serum methylprednisolone levels following intra-articular injection of methylprednisolone acetate. Ann Rheum Dis 1981;40:571-574.
12. Wicki J, Droz M, Cirafici L, et al. Acute adrenal crisis in a patient treated with intraarticular steroid therapy. J Rheumatol 2000;27:510-511.
13. Mace S, Vadas P, Pruzanski W. Anaphylactic shock induced by intraarticular injection of methylprednisolone acetate. J Rheumatol 1997;24:1191-1194.
14. Luo Y, Uboh CE, Soma LR, et al. Stereochemical differentiation, quantification and confirmation of betamethasone and dexamethasone in equine plasma by liquid chromatography-triple stage quadrupole tandem mass spectrometry. Rapid Commun Mass Spectrom 2005;19:1245-1256.
15. Luo Y, Uboh CE, Soma LR, et al. Detection, quantification and confirmation of twenty-one glucocorticoids in equine plasma by LC/ TSQ-ESI-MS/MS. Rapid Commun Mass Spectrom 2005;19:825-832.
16. Wastney ME, Patterson BH, Linares OA, et al. Investigating biological systems using modeling: strategies and software. New York: Academic Press Inc, 1999;129.
17. Stefanovski D, Moate PJ, Boston RC. WinSAAM: a windows based compartmental modeling system. Metabolism 2003;52:1153-1166.
18. Boston RC, Greif PC, Bermn M. Conversational SAAM: an interactive program for kinetic analysis of biological systems. Comput Programs Biomed 1981;13:111-119.
19. Naylor JR, Bayly WM, Schott HC II, et al. Equine plasma and blood volumes decrease with dehydration but subsequently increase with exercise. J Appl Physiol 1993;75:1002-1008.
20. Muir WW, Kohn CW, Sams R. Effects of furosemide on plasma volume and extracellular fluid volume in horses. Am J Vet Res 1978;39:1688-1691.
21. Soma LR, Uboh CE, Guan F, et al. The pharmacokinetics of hemoglobin-based oxygen carrier hemoglobin glutamer-200 bovine in the horse. Anesth Analg 2005;100:1570-1575.
22. Berman M, Schoenfeld R. invariants in experimental data on linear kinetics and the formulation of models. J Appl Phys 1965;27:1361-1370.
23. Powers J. Statistical analysis of pharmacokinetic data. J Vet Pharmacol Ther 1990;13:113-120.
24. Alvinerie M, Toutain PL. Determination of methylprednisolone and methylprednisolone acetate in synovial fluid using high-performance liquid chromatography. J Chromatogr 1984;309:385-390.
25. Antal EJ, Wright CE III, Gillespie WR, et al. Influence of route of administration on the pharmacokinetics of methylprednisolone. J Pharmacohinet Biopharm 1983;11:561-576.
26. Tornatore KM, Logue G, Venuto RC, et al. Pharmacokinetics of methylprednisolone in elderly and young healthy males. J Am Geriatr Soc 1994;42:1118-1122.
27. Keller-Wood ME, Dallman MF. Corticosteroid inhibition of ACTH secretion. Endocr Rev 1984;5:1-24.
28. Keller-Wood M, Leeman E, Shinsako J, et al. Steroid inhibition of canine ACTH: in vivo evidence for feedback at the corticotrope. Am J Physiol 1988;255:E241-E246.
29. Keller-Wood M. Control of canine ACTH by corticosteroids: an integral feedback effect of steroids. Am J Physiol 1989;257:R427-R430.
30. Lypka A, Szczudlik A. Dexamethasone suppresses cortisol but not ACTH and beta-endorphin plasma concentration in healthy man. Horm Metab Res 1985;17:547-557.
31. Koopmans RP, Braat MC, Oosterhuis B, et al. Time-dependent effects of dexamethasone administration on the suppression of plasma hydrocortisone, assessed with a pharmacokinetic model. J Pharmacol Exp Ther 1992;262:503-508.
32. Lassourd V, Gayrard V, Laroute V, et al. Cortisol disposition and production rate in horses during rest and exercise. Am J Physiol 1996;271:25-33.
33. Soma LR, Uboh CE, Luo Y, et al. Pharmacokinetics of dexamethasone with pharmacokinetic/pharmacodynamic model of the effect of dexamethasone on endogenous hydrocortisone and cortisone in the horse. J Vet Pharmacol Ther 2005;28:71-80.
34. Toothaker RD, Welling PG. Effect of dose size on the pharmacokinetics of intravenous hydrocortisone during endogenous hydrocortisone suppression. J Pharmacokinet Biopharm 1982; 10:147-156.
35. Jusko WJ. Receptor-mediated pharmacodynamics of corticosteroids. Progress in clinical and biological research, in Proceedings. 5th Int Conf Carcinog Risk Assess 1994;378:261-270.
36. Nelson DL, Cox MM. Lipids. In: Lehnenger principles of biochemistry. 2nd ed. New York: Worth Publishers, 2000;378-379.
37. Toutain PL, Laurentie M, Autefage A, et al. Hydrocortisone secretion: production rate and pulse characterization by numerical deconvolution. Am J Physiol 1988;255:E688-E695.
38. Booker BM, Magee MH, Blum RA, et al. Pharmacokinetic and pharmacodynamic interactions between diltiazem and methylprednisolone in healthy volunteers. Clin Pharmacol Ther 2002; 72:370-382.
39. Chow FS, Sharma A, Jusko WJ. Modeling interactions between adrenal suppression and T-helper lymphocyte trafficking during multiple dosing of methylprednisolone. J Pharmacokinet Biopharm 1999;27:559-575.
40. Piekoszewski W, Chow FS, Jusko WJ. Pharmacokinetic and pharmacodynamic effects of coadministration of methylprednisolone and tacrolimus in rabbits. J Pharmacol Exp Ther 1994;269:103-109.
41. Derendorf H, Hochhaus G, Mollmann H, et al. Receptor-based pharmacokinetic-pharmacodynamic analysis of corticosteroids. J Clin Pharmacol 1993;33:115-123.
42. Toutain PL, Brandon RA, De Pomyers H, et al. Dexamethasone and prednisolone in the horse: pharmacokinetics and action on the adrenal gland. Am J Vet Res 1984;45:1750-1756.
43. Alexander SL, Irvine CH, Donald RA. Short-term secretion patterns of corticotropin-releasing hormone, arginine vasopressin and ACTH as shown by intensive sampling of pituitary venous blood from horses. Neuroendocrinology 1994;60:225-236.
44. Irvine CH, Alexander SL. Factors affecting the circadian rhythm in plasma cortisol concentrations in the horse. Domest Anim Endocrinol 1994;11:227-238.
45. Toutain PL, Oukessou M, Autefage A, et al. Diurnal and episodic variations of plasma hydrocortisone concentrations in horses. Domest Anim Endocrinol 1988;5:55-59.
46. MacHarg MA, Bottoms GD, Carter GK, et al. Effects of multiple intramuscular injections and doses of dexamethasone on plasma cortisol concentrations and adrenal responses to ACTH in horses. Am J Vet Res 1985;46:2285-2287.
47. Eiler H, Oliver J, Goble D. Adrenal gland function in the horse: effect of dexamethasone on hydrocortisone secretion and blood cellularity and plasma electrolyte concentrations. Am J Vet Res 1979;40:727-729.
48. Hoffsis GF, Murdick PW, Tharp VL, et al. Plasma concentrations of cortisol and corticosterone in the normal horse. Am J Vet Res 1970;31:1379-1387.
49. James VH, Horner MW, Moss MS, et al. Adrenocortical function in the horse. J Endocrinol 1970;48:319-335.
50. Stewart PM. The adrenal cortex. In: Larson PR, Kronenberg HM, Melmed S, et al, eds. Williams textbook of endocrinology. 10th ed. Philadelphia: WB Saunders Co, 2003;496-508.